Latest Biotech News

Emerging evidence reveals the tumor suppressor gene CHEK2 not only functions in DNA repair but also modulates anti-tumor immunity in solid cancers. CHEK2 deficiency disrupts homologous...

The US Food and Drug Administration (FDA) has introduced a new pilot commissioner’s national priority voucher program aimed at accelerating review times for biotech companies. Announced alongside...

Vertex Pharmaceuticals has demonstrated promising clinical data for its off-the-shelf stem cell therapy aimed at type 1 diabetes, with 10 out of 12 patients stopping insulin injections a year...

Prothena, an Irish biotech focused on protein dysregulation diseases, is undertaking a major workforce reduction, laying off 63% of employees following the failure of its phase 3 amyloidosis drug...

A novel analysis published in Oncotarget highlights the immunomodulatory role of CHEK2 gene deficiency in solid tumors, extending beyond its classical DNA repair functions. Loss of CHEK2 impairs...

Researchers at Xi’an Jiaotong-Liverpool University and Nanjing University have developed a novel nanoparticle drug delivery system combining PLGA polymer with albumin protein, yielding...

An advanced semi-supervised fusion architecture leveraging speech embeddings has been developed to detect Parkinson's disease with high sensitivity. This AI system analyzes nuanced vocal features...

A University of North Carolina study using AlphaFold 3 protein structure predictions combined with AI and physics-based modeling reveals that the H5N1 avian influenza virus has evolved mutations...

Data from Novo Nordisk's Phase 1/2 trial of the obesity treatment amycretin reveal substantial weight loss gains but atypical dose-response curves and notable adverse event rates. At the American...

The Michael J. Fox Foundation (MJFF) introduced the Targets to Therapies (T2T) initiative, focusing on accelerating validation and tool development for 21 prioritized molecular targets in...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the authorization of five new drugs, four of which already hold US approvals. Additionally, CHMP...

The U.S. Food and Drug Administration (FDA) has unveiled a new pilot program granting biotechnology companies a priority voucher that shortens drug review times by one to two months, aiming to...

Vertex Pharmaceuticals presented promising data from clinical trials of its off-the-shelf stem cell therapy, zimislecel (formerly VX-880), for type 1 diabetes. The Phase 1/2 study showed that 10...

Novo Nordisk’s amycretin, a next-generation amylin analog for obesity, demonstrated significant weight loss in a Phase 1/2 trial, with the highest 60 mg dose yielding average 24.3% weight...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for five new drugs, including Madrigal’s Rezdiffra (resmetirom) for metabolic...

A novel review highlights the dual role of the tumor suppressor gene CHEK2 in enhancing the efficacy of immune checkpoint inhibitors (ICIs) for solid tumors. CHEK2 deficiency drives increased...

Recent reviews underscore rapid advancements in remote photoplethysmography (rPPG) combined with deep learning techniques for non-invasive heart rate measurement using standard cameras....

Prothena Corporation has announced a significant workforce reduction, laying off 63% of employees after its monoclonal antibody birtamimab failed to improve mortality in a Phase 3 trial for Mayo...

Researchers at Xi’an Jiaotong-Liverpool University and Nanjing University have developed a novel nanoparticle system combining PLGA polymer with albumin, achieving ultra-high colloidal stability...

A Nature Communications study has introduced a cutting-edge genetic barcoding approach to monitor how cancer cells dynamically adapt and develop drug resistance over time. By tagging individual...